Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-12 Sale |
2022-08-16 6:57 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
286,539 | $0 | $0 | 0 (Direct) |
View |
| 2022-06-07 Sale |
2022-06-08 4:03 pm |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
841 | $21.89 | $18,409 | 1,840 (Direct) |
View |
| 2022-06-03 Sale |
2022-06-06 4:40 pm |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
807 | $22.8 | $18,400 | 1,874 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:40 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
1,058 | $1.5 | $1,587 | 156,385 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-04 4:15 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
2,639 | $1.37 | $3,615 | 157,443 (Direct) |
View |
| 2022-01-26 Sale |
2022-01-28 4:15 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
2,922 | $2.02 | $5,902 | 160,082 (Direct) |
View |
| 2021-12-06 Sale |
2021-12-07 7:03 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
1,780 | $2.93 | $5,215 | 163,004 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:41 pm |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
969 | $11.21 | $10,862 | 104,341 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:38 pm |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
2,872 | $11.41 | $32,770 | 75,727 (Direct) |
View |
| 2020-12-03 Sale |
2020-12-07 07:00 am |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
2,522 | $13.54 | $34,148 | 76,089 (Direct) |
View |
| 2020-06-26 Sale |
2020-06-30 08:56 am |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
1,805 | $16.15 | $29,151 | 78,611 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-04 Other |
2025-04-08 8:56 pm |
N/A 2033-06-15 |
Gritstone bio Inc. | GRTS | Agarwal Shefali Director |
161,537 | $0 | 0 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 6:19 pm |
N/A 2034-06-16 |
Gritstone bio Inc. | GRTS | Agarwal Shefali Director |
51,800 | $0 | 51,800 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:28 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:47 pm |
N/A 2033-06-15 |
Gritstone bio Inc. | GRTS | Agarwal Shefali Director |
51,800 | $0 | 51,800 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:05 pm |
N/A 2033-06-06 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 8:53 pm |
N/A N/A |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
500,000 | $1.39 | 1,129,035 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 8:53 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
500,000 | $0 | 1,129,035 (Direct) |
View |
| 2022-08-09 Tax Withholding |
2022-08-11 8:53 pm |
N/A N/A |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
373,154 | $1.39 | 1,129,035 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 5:29 pm |
N/A 2032-06-16 |
Gritstone bio Inc. | GRTS | Agarwal Shefali Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:38 pm |
N/A 2032-06-09 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
20,543 | $0 | 22,383 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-21 6:05 pm |
N/A N/A |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
2,331 | $1.2665 | 658,716 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-21 6:05 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
500,000 | $0 | 658,716 (Direct) |
View |
| 2021-06-18 Option Award |
2021-11-19 5:52 pm |
N/A 2031-06-17 |
Gritstone bio Inc. | GRTS | Agarwal Shefali Director |
937 | $0 | 937 (Direct) |
View |
| 2021-06-01 Option Award |
2021-11-19 5:48 pm |
N/A 2031-05-31 |
Gritstone bio Inc. | GRTS | Agarwal Shefali Director |
38,000 | $0 | 38,000 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-18 08:00 am |
N/A 2031-08-15 |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
341,436 | $0 | 445,777 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:26 pm |
N/A 2031-06-01 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
7,015 | $0 | 7,015 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:12 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
170,718 | $0 | 246,445 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-30 08:56 am |
N/A N/A |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
6,000 | $0 | 78,611 (Direct) |
View |
| 2020-05-01 Option Award |
2020-05-05 4:09 pm |
N/A 2030-05-01 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
16,000 | $0 | 16,000 (Direct) |
View |